Endocrine Therapies and QTc Prolongation
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2010 |
|---|---|
| Erschienen: |
2010 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:5 |
|---|---|
| Enthalten in: |
Current drug safety - 5(2010), 1 vom: 1. Jan., Seite 79-85 |
| Beteiligte Personen: |
Navone, Stefania [VerfasserIn] |
|---|
| Umfang: |
6 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
OLC1832589781 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | OLC1832589781 | ||
| 003 | DE-627 | ||
| 005 | 20230516181739.0 | ||
| 007 | tu | ||
| 008 | 100111s2010 xx ||||| 00| ||und c | ||
| 028 | 5 | 2 | |a sw100105_1 |
| 035 | |a (DE-627)OLC1832589781 | ||
| 035 | |a (DE-599)GBVOLC1832589781 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 082 | 0 | 4 | |a 610 |
| 084 | |a PHARM |2 fid | ||
| 100 | 1 | |a Navone, Stefania |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Endocrine Therapies and QTc Prolongation |
| 264 | 1 | |c 2010 | |
| 300 | |a 6 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 700 | 1 | |a Cristini, Silvia |4 oth | |
| 700 | 1 | |a Canzi, Laura |4 oth | |
| 700 | 1 | |a Parati, Eugenio A. |4 oth | |
| 700 | 1 | |a Invernici, Gloria |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Current drug safety |d Sharjah : Bentham Science, 2006 |g 5(2010), 1 vom: 1. Jan., Seite 79-85 |w (DE-627)517812185 |w (DE-600)2250840-5 |w (DE-576)435514229 |x 1574-8863 |7 nnns |
| 773 | 1 | 8 | |g volume:5 |g year:2010 |g number:1 |g day:1 |g month:01 |g pages:79-85 |g extent:6 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a FID-PHARM | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 912 | |a SSG-OPC-PHA | ||
| 912 | |a GBV_ILN_20 | ||
| 912 | |a GBV_ILN_4219 | ||
| 951 | |a AR | ||
| 952 | |d 5 |j 2010 |e 1 |b 1 |c 1 |h 79-85 |g 6 | ||